Cancer Research Cancer Genome no Abstract  AM No Date
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Méniel, V.
Right arrow Articles by Clarke, A. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Méniel, V.
Right arrow Articles by Clarke, A. R.
[Cancer Research 65, 410-416, January 15, 2005]
© 2005 American Association for Cancer Research


Molecular Biology, Pathobiology and Genetics

Mutations in Apc and p53 Synergize to Promote Mammary Neoplasia

Valérie Méniel1, Trevor Hay1, Anthony Douglas-Jones2, Owen J. Sansom1 and Alan R. Clarke1

1 School of Biological Sciences, Cardiff University and 2 Department of Pathology, University of Wales College of Medicine, Cardiff, United Kingdom

Requests for reprints: Alan R. Clarke, School of Biological Sciences, Cardiff University, Cardiff CF103US, United Kingdom. Phone: 44-2920-874609; Fax: 44-2920-874116; E-mail: clarkear{at}cf.ac.uk.

Mutations of Apc and p53 have both been implicated in human and murine mammary neoplasia. To investigate potential interactions between Apc and p53, we conditionally inactivated Apc in both the presence and the absence of functional p53. Apc deficiency on its own leads to the development of metaplasia but not neoplasia. We show here that these areas of metaplasia are characterized by elevated levels of both p53 and p21. In the additional absence of p53,there is rapid progression to neoplasia, with 44.4% of lymphoma-free mice developing a mammary tumor with earliest observed onset at pregnancy. To investigate the mechanism by which p53 deficiency accelerates neoplasia, we used the Rosa26R reporter strain as a marker of Cre-mediated recombination and show a role for p53 in the loss of Apc-deficient cells. This role seems limited to pregnancy and subsequent time points. We therefore show clear synergy between these two mutations in mammary gland neoplasia and present data to suggest that at least one mechanism for this acceleration is the p53-dependent loss of Apc-deficient cells.

Key Words: Apc • p53 • mammary • tumorigenesis




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
X. Wang, E. L. Goode, Z. S. Fredericksen, R. A. Vierkant, V. S. Pankratz, W. Liu-Mares, D. N. Rider, C. M. Vachon, J. R. Cerhan, J. E. Olson, et al.
Association of Genetic Variation in Genes Implicated in the {beta}-Catenin Destruction Complex with Risk of Breast Cancer
Cancer Epidemiol. Biomarkers Prev., August 1, 2008; 17(8): 2101 - 2108.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Thiagalingam
A cascade of modules of a network defines cancer progression.
Cancer Res., August 1, 2006; 66(15): 7379 - 7385.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.